A carregar...
Efficacy and Safety of Rituximab for Refractory and Relapsing Thrombotic Thrombocytopenic Purpura: A Cohort of 10 Cases
OBJECTIVE: Idiopathic thrombotic thrombocytopenic purpura (TTP) is a life-threatening disorder mediated by autoantibodies directed against ADAMTS13. This provides a rationale for the use of rituximab in this disorder. We report our experience and the outcome of 10 cases of TTP (9 refractory and 1 re...
Na minha lista:
| Publicado no: | Clin Med Insights Blood Disord |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Libertas Academica
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4451552/ https://ncbi.nlm.nih.gov/pubmed/26052230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMBD.S25326 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|